Cidara Therapeutics (CDTX) Revenue & Revenue Breakdown
Cidara Therapeutics Revenue Highlights
Latest Revenue (Y)
$63.91M
Latest Revenue (Q)
$8.46M
Cidara Therapeutics Revenue by Period
Cidara Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $63.91M | -0.60% |
| 2022-12-31 | $64.29M | 29.69% |
| 2021-12-31 | $49.57M | 310.81% |
| 2020-12-31 | $12.07M | -42.30% |
| 2019-12-31 | $20.91M | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2013-12-31 | - | - |
Cidara Therapeutics generated $63.91M in revenue during NA 2023, up -0.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Cidara Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $8.46M | -51.87% |
| 2023-12-31 | $17.58M | 38.25% |
| 2023-09-30 | $12.72M | 67.03% |
| 2023-06-30 | $7.61M | -70.70% |
| 2023-03-31 | $25.99M | 154.33% |
| 2022-12-31 | $10.22M | -74.92% |
| 2022-09-30 | $40.74M | 555.47% |
| 2022-06-30 | $6.22M | -12.56% |
| 2022-03-31 | $7.11M | -1.61% |
| 2021-12-31 | $7.22M | 2.11% |
| 2021-09-30 | $7.08M | -78.47% |
| 2021-06-30 | $32.86M | 1264.74% |
| 2021-03-31 | $2.41M | -35.43% |
| 2020-12-31 | $3.73M | 54.35% |
| 2020-09-30 | $2.42M | -28.77% |
| 2020-06-30 | $3.39M | 34.07% |
| 2020-03-31 | $2.53M | 39.39% |
| 2019-12-31 | $1.81M | -90.50% |
| 2019-09-30 | $19.10M | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | 100.00% |
| 2014-06-30 | - | 100.00% |
| 2014-03-31 | - | - |
Cidara Therapeutics generated $8.46M in revenue during Q1 2024, up -51.87% compared to the previous quarter, and up 82.82% compared to the same period a year ago.
Cidara Therapeutics Revenue Breakdown
Cidara Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 23 | Jun 21 | Mar 21 |
|---|---|---|---|
| Collaboration Revenue | $7.61M | $32.86M | $2.41M |
Cidara Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Collaboration Revenue (100.00%).
CDTX Revenue FAQ
What is Cidara Therapeutics’s yearly revenue?
Cidara Therapeutics's yearly revenue for 2023 was $63.9M, representing a decrease of -0.60% compared to 2022. The company's yearly revenue for 2022 was $64.29M, representing an increase of 29.69% compared to 2021. CDTX's yearly revenue for 2021 was $49.57M, representing an increase of 310.81% compared to 2020.
What is Cidara Therapeutics’s quarterly revenue?
Cidara Therapeutics's quarterly revenue for Q1 2024 was $8.46M, a -51.87% decrease from the previous quarter (Q4 2023), and a -67.44% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $17.58M, a 38.25% increase from the previous quarter (Q3 2023), and a 72.06% increase year-over-year (Q4 2022). CDTX's quarterly revenue for Q3 2023 was $12.72M, a 67.03% increase from the previous quarter (Q2 2023), and a -68.79% decrease year-over-year (Q3 2022).
What is Cidara Therapeutics’s revenue growth rate?
Cidara Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 28.91%, and for the last 5 years (2019-2023) was 205.55%.